DRKS00008551RecruitingNot Applicable
Healthcare research multiple myeloma: latencies to diagnosis and treatment
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- niversitätsklinikum Freiburg
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Patients with multiple myeloma
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Not Applicable
Healthcare research multiple myeloma - analysis in patient referring physician and participation satisfaction concerning the interdisciplinary CCF MM-tumorboard.C90.0Multiple myelomaDRKS00008573niversitätsklinikum Freiburg100
Completed
Not Applicable
Healthcare research multiple myeloma (MM) - parameters to be assessed within the evaluation of the MM-Tumorboard (TB).C90.0Multiple myelomaDRKS00008587niklinik Freiburg299
Completed
Not Applicable
High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal ImpairmentMultiple MyelomaRenal FailureNCT03234335Centre Hospitalier Universitaire de Saint Etienne50
Active, not recruiting
Phase 1
Impact of lenalidomide on immune cell expression in multiple myelomaMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2021-000987-31-FRCHU Rennes22
Terminated
Not Applicable
CAR-T Cells Therapy in Relapsed/Refractory Multiple MyelomaRelapsed/Refractory Multiple Myeloma(MM)NCT03473496Zhujiang Hospital2